Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
or

Charles River Laboratories Intl (CRL)

Charles River Laboratories Intl (CRL)
99.95 x 1 107.57 x 1
Post-market by (Cboe BZX)
102.67 -3.38 (-3.19%) 04/21/25 [NYSE]
99.95 x 1 107.57 x 1
Post-market 102.67 unch (unch) 16:43 ET
Quote Overview for Mon, Apr 21st, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
99.80
Day High
103.91
Open 103.90
Previous Close 106.05 106.05
Volume 2,087,326 2,087,326
Avg Vol 2,324,441 2,324,441
Stochastic %K 21.32% 21.32%
Weighted Alpha -57.07 -57.07
5-Day Change +2.92 (+2.93%) +2.92 (+2.93%)
52-Week Range 91.86 - 254.15 91.86 - 254.15
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 5,208,752
  • Shares Outstanding, K 49,116
  • Annual Sales, $ 4,050 M
  • Annual Income, $ 22,200 K
  • EBIT $ 581 M
  • EBITDA $ 1,158 M
  • 60-Month Beta 1.45
  • Price/Sales 1.26
  • Price/Cash Flow 4.80
  • Price/Book 1.54

Options Overview Details

View History
  • Implied Volatility 74.13% ( +1.37%)
  • Historical Volatility 109.18%
  • IV Percentile 98%
  • IV Rank 79.30%
  • IV High 86.39% on 04/11/25
  • IV Low 27.14% on 08/16/24
  • Put/Call Vol Ratio 0.14
  • Today's Volume 1,124
  • Volume Avg (30-Day) 846
  • Put/Call OI Ratio 0.25
  • Today's Open Interest 9,386
  • Open Int (30-Day) 5,405

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 15 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate 2.06
  • Number of Estimates 8
  • High Estimate 2.09
  • Low Estimate 2.01
  • Prior Year 2.27
  • Growth Rate Est. (year over year) -9.25%

Price Performance

See More
Period Period Low Period High Performance
1-Month
91.86 +11.77%
on 04/11/25
Period Open: 167.28
169.26 -39.34%
on 03/24/25
-64.61 (-38.62%)
since 03/21/25
3-Month
91.86 +11.77%
on 04/11/25
Period Open: 169.81
181.44 -43.41%
on 03/10/25
-67.14 (-39.54%)
since 01/21/25
52-Week
91.86 +11.77%
on 04/11/25
Period Open: 226.78
254.15 -59.60%
on 08/01/24
-124.11 (-54.73%)
since 04/19/24

Most Recent Stories

More News
The 2 Worst Performing S&P 500 Stocks YTD: Buy, Sell, or Avoid?

Amid market turbulence and policy shifts, do two of the S&P 500’s steepest decliners, DECK and CRL, offer deep value or signal deeper trouble ahead?

DECK : 103.55 (-2.01%)
CRL : 102.67 (-3.19%)
SPY : 513.88 (-2.38%)
FDA’s Intent To Phase Out Animal Testing Requirement Weighs Down Charles River Stock: Retail’s Disheartened

JPMorgan, which holds a ‘Neutral’ rating on the stock, opined that Charles River could see disruption from customers reassessing its preclinical strategies in the near term.

VOO : 472.37 (-2.38%)
VTI : 252.60 (-2.38%)
CRL : 102.67 (-3.19%)
Stocks Fall Sharply as Tariff Concerns Weigh on Growth Prospects

The S&P 500 Index ($SPX ) (SPY ) Thursday closed down -3.46%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -2.50%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -4.19%. June E-mini...

GOOGL : 147.67 (-2.31%)
MPC : 126.72 (-0.78%)
AAPL : 193.16 (-1.94%)
ADI : 174.99 (-0.73%)
LVS : 32.56 (-0.64%)
SLB : 34.62 (-1.40%)
WYNN : 74.96 (+0.25%)
OXY : 39.02 (-1.74%)
TSLA : 227.50 (-5.75%)
FANG : 132.35 (-3.84%)
AMD : 85.56 (-2.22%)
SPY : 513.88 (-2.38%)
How Is Charles River Laboratories' Stock Performance Compared to Other Health Care Stocks?

As Charles River Laboratories has underperformed its industry peers recently, analysts remain cautious about the stock’s prospects.

MEDP : 288.99 (-2.46%)
XLV : 132.57 (-2.16%)
CRL : 102.67 (-3.19%)
Drug Development Inputs & Services Stocks Q4 In Review: Medpace (NASDAQ:MEDP) Vs Peers

Drug Development Inputs & Services Stocks Q4 In Review: Medpace (NASDAQ:MEDP) Vs Peers

MEDP : 288.99 (-2.46%)
FTRE : 5.20 (-1.70%)
AZTA : 25.03 (-0.87%)
RGEN : 131.64 (+1.26%)
CRL : 102.67 (-3.19%)
3 Reasons CRL is Risky and 1 Stock to Buy Instead

3 Reasons CRL is Risky and 1 Stock to Buy Instead

YUM : 140.51 (-1.95%)
CRL : 102.67 (-3.19%)
Unpacking Q4 Earnings: UFP Technologies (NASDAQ:UFPT) In The Context Of Other Drug Development Inputs & Services Stocks

Unpacking Q4 Earnings: UFP Technologies (NASDAQ:UFPT) In The Context Of Other Drug Development Inputs & Services Stocks

FTRE : 5.20 (-1.70%)
UFPT : 210.63 (-0.20%)
AZTA : 25.03 (-0.87%)
WST : 205.88 (+1.97%)
CRL : 102.67 (-3.19%)
Spotting Winners: Charles River Laboratories (NYSE:CRL) And Drug Development Inputs & Services Stocks In Q4

Spotting Winners: Charles River Laboratories (NYSE:CRL) And Drug Development Inputs & Services Stocks In Q4

FTRE : 5.20 (-1.70%)
MEDP : 288.99 (-2.46%)
AZTA : 25.03 (-0.87%)
CRL : 102.67 (-3.19%)
IQV : 141.22 (-1.87%)
Charles River Laboratories Stock Outlook: Is Wall Street Bullish or Bearish?

Charles River Laboratories has lagged behind the broader market over the past year, with Wall Street analysts maintaining a cautious outlook on its future performance.

XLV : 132.57 (-2.16%)
$SPX : 5,158.20 (-2.36%)
JPM : 228.99 (-1.28%)
CRL : 102.67 (-3.19%)
UFP Technologies (UFPT) Reports Q4: Everything You Need To Know Ahead Of Earnings

UFP Technologies (UFPT) Reports Q4: Everything You Need To Know Ahead Of Earnings

UFPT : 210.63 (-0.20%)
AZTA : 25.03 (-0.87%)
CRL : 102.67 (-3.19%)
S&P 500 Index Funds Yield Just 1.3%. Consider Buying These 2 Low-Cost Vanguard ETFs to Generate More Passive Income.

The heaviest weighted components of the S&P 500 are companies like Apple, Microsoft , and Nvidia -- tech leaders that tend to reward their shareholders largely through their rising stock prices rather...

MGK : 284.39 (-2.78%)
MSFT : 359.12 (-2.35%)
NVDA : 96.91 (-4.51%)
AAPL : 193.16 (-1.94%)
VIG : 180.17 (-2.01%)
VOO : 472.37 (-2.38%)
VYM : 118.70 (-1.77%)
Cool, Calm, and Collected: 2 Dividend ETFs to Buy During the S&P 500 Sell-Off

A stock market correction occurs when a major index falls 10% off its highs. The S&P 500 (SNPINDEX: ^GSPC) hit that level Thursday, falling almost 1.4% to end the day 10.1% below its all-time high set...

COMP : 6.86 (-5.90%)
$NASX : 15,870.90 (-2.55%)
KO : 72.77 (-0.32%)
VIG : 180.17 (-2.01%)
$SPX : 5,158.20 (-2.36%)
JNJ : 156.92 (-0.35%)
VYM : 118.70 (-1.77%)
WMT : 92.41 (-0.87%)
The Nasdaq Just Hit Correction Territory: Is It Time to Buy Dividend Stocks?

The Nasdaq Composite (NASDAQINDEX: ^IXIC) has fallen more than 10% from a recent high. That's a key level known as a correction, which is the first stop as Wall Street heads toward a bear market. A bear...

DIV : 17.34 (-1.31%)
COMP : 6.86 (-5.90%)
$NASX : 15,870.90 (-2.55%)
SCHD : 25.03 (-1.53%)
VYM : 118.70 (-1.77%)
Vanguard High Dividend Yield ETF vs Vanguard Dividend Appreciation ETF: Which Is Best for You?

Vanguard has some excellent dividend ETFs, but they are right for different investors.

AAPL : 193.16 (-1.94%)
AVGO : 166.21 (-2.80%)
BAC : 36.92 (-1.31%)
JPM : 228.99 (-1.28%)
JNJ : 156.92 (-0.35%)
VYM : 118.70 (-1.77%)
ABBV : 170.16 (-1.64%)
UNH : 425.33 (-6.34%)
MSFT : 359.12 (-2.35%)
COST : 957.77 (-3.69%)
MA : 509.32 (-1.55%)
VIG : 180.17 (-2.01%)
Is the Vanguard High Dividend Yield ETF the Smartest Investment You Can Make Today?

It hasn't been the best start to 2025 for the major indexes of the U.S. stock market. As of March 7, the S&P 500 is down, the Nasdaq Composite is down, and the Dow Jones is essentially flat. However, this...

COMP : 6.86 (-5.90%)
VYM : 118.70 (-1.77%)
Best Stocks in the World? This ETF Is Crushing the S&P 500 in 2025.

The U.S. stock market hasn't exactly started 2025 on a high note. Through the first week of March, the S&P 500 has fallen by 2%, and the tech-heavy Nasdaq Composite is down by 6%.

TD : 60.82 (+0.20%)
COMP : 6.86 (-5.90%)
VYMI : 72.76 (-0.32%)
TM : 174.52 (-1.05%)
SHEL : 64.65 (-0.60%)
VYM : 118.70 (-1.77%)
NSRGY : 107.9500 (+0.19%)
3 Steady ETFs for Cautious Investors Facing Market Turbulence

With volatility surging, high-quality ETFs that blend steady dividends and broad market exposure offer a reliable strategy for long-term growth.

SCHD : 25.03 (-1.53%)
VYM : 118.70 (-1.77%)
SPHD : 46.21 (-1.93%)
Want Decades of Passive Income? Buy This ETF and Hold It Forever.

You don't need to do anything extraordinary to create a solid stream of income with upside potential. There are some excellent low-cost exchange-traded funds, or ETFs, that specialize in dividend stocks....

AVGO : 166.21 (-2.80%)
JPM : 228.99 (-1.28%)
XOM : 105.35 (-1.47%)
VYM : 118.70 (-1.77%)
WMT : 92.41 (-0.87%)
3 Dividend Stock ETFs to Buy With $2,000 and Hold Forever

There is no shortage of excellent, low-cost exchange-traded funds (ETFs) that specialize in dividend stocks. There are some that focus on stocks that pay above-average dividends, stocks whose dividends...

AAPL : 193.16 (-1.94%)
AVGO : 166.21 (-2.80%)
VIG : 180.17 (-2.01%)
JPM : 228.99 (-1.28%)
VYMI : 72.76 (-0.32%)
VNQ : 85.03 (-2.08%)
AMT : 217.99 (-2.10%)
TM : 174.52 (-1.05%)
PLD : 98.63 (-3.40%)
VYM : 118.70 (-1.77%)
EQIX : 773.20 (-2.15%)
Boost Your Income! Why This Closed-End Fund Surpasses Vanguard's High Dividend Yield ETF

Vanguard High Dividend Yield ETF (NYSEMKT: VYM) is a fairly easy to understand exchange-traded fund (ETF) with an income focus. There's just one glaring problem with the ETF: Its yield isn't exactly huge...

$SPX : 5,158.20 (-2.36%)
GDV : 22.05 (-2.00%)
VYM : 118.70 (-1.77%)
S&P 500 Index Funds Yield Just 1.3%. Consider Buying These 2 Low-Cost Vanguard ETFs to Generate More Passive Income.

The heaviest weighted components of the S&P 500 are companies like Apple, Microsoft , and Nvidia -- tech leaders that tend to reward their shareholders largely through their rising stock prices rather...

MGK : 284.39 (-2.78%)
MSFT : 359.12 (-2.35%)
NVDA : 96.91 (-4.51%)
AAPL : 193.16 (-1.94%)
VIG : 180.17 (-2.01%)
VOO : 472.37 (-2.38%)
VYM : 118.70 (-1.77%)
Cool, Calm, and Collected: 2 Dividend ETFs to Buy During the S&P 500 Sell-Off

A stock market correction occurs when a major index falls 10% off its highs. The S&P 500 (SNPINDEX: ^GSPC) hit that level Thursday, falling almost 1.4% to end the day 10.1% below its all-time high set...

COMP : 6.86 (-5.90%)
$NASX : 15,870.90 (-2.55%)
KO : 72.77 (-0.32%)
VIG : 180.17 (-2.01%)
$SPX : 5,158.20 (-2.36%)
JNJ : 156.92 (-0.35%)
VYM : 118.70 (-1.77%)
WMT : 92.41 (-0.87%)
The Nasdaq Just Hit Correction Territory: Is It Time to Buy Dividend Stocks?

The Nasdaq Composite (NASDAQINDEX: ^IXIC) has fallen more than 10% from a recent high. That's a key level known as a correction, which is the first stop as Wall Street heads toward a bear market. A bear...

DIV : 17.34 (-1.31%)
COMP : 6.86 (-5.90%)
$NASX : 15,870.90 (-2.55%)
SCHD : 25.03 (-1.53%)
VYM : 118.70 (-1.77%)
Vanguard High Dividend Yield ETF vs Vanguard Dividend Appreciation ETF: Which Is Best for You?

Vanguard has some excellent dividend ETFs, but they are right for different investors.

AAPL : 193.16 (-1.94%)
AVGO : 166.21 (-2.80%)
BAC : 36.92 (-1.31%)
JPM : 228.99 (-1.28%)
JNJ : 156.92 (-0.35%)
VYM : 118.70 (-1.77%)
ABBV : 170.16 (-1.64%)
UNH : 425.33 (-6.34%)
MSFT : 359.12 (-2.35%)
COST : 957.77 (-3.69%)
MA : 509.32 (-1.55%)
VIG : 180.17 (-2.01%)
Is the Vanguard High Dividend Yield ETF the Smartest Investment You Can Make Today?

It hasn't been the best start to 2025 for the major indexes of the U.S. stock market. As of March 7, the S&P 500 is down, the Nasdaq Composite is down, and the Dow Jones is essentially flat. However, this...

COMP : 6.86 (-5.90%)
VYM : 118.70 (-1.77%)
Best Stocks in the World? This ETF Is Crushing the S&P 500 in 2025.

The U.S. stock market hasn't exactly started 2025 on a high note. Through the first week of March, the S&P 500 has fallen by 2%, and the tech-heavy Nasdaq Composite is down by 6%.

TD : 60.82 (+0.20%)
COMP : 6.86 (-5.90%)
VYMI : 72.76 (-0.32%)
TM : 174.52 (-1.05%)
SHEL : 64.65 (-0.60%)
VYM : 118.70 (-1.77%)
NSRGY : 107.9500 (+0.19%)
3 Steady ETFs for Cautious Investors Facing Market Turbulence

With volatility surging, high-quality ETFs that blend steady dividends and broad market exposure offer a reliable strategy for long-term growth.

SCHD : 25.03 (-1.53%)
VYM : 118.70 (-1.77%)
SPHD : 46.21 (-1.93%)
Want Decades of Passive Income? Buy This ETF and Hold It Forever.

You don't need to do anything extraordinary to create a solid stream of income with upside potential. There are some excellent low-cost exchange-traded funds, or ETFs, that specialize in dividend stocks....

AVGO : 166.21 (-2.80%)
JPM : 228.99 (-1.28%)
XOM : 105.35 (-1.47%)
VYM : 118.70 (-1.77%)
WMT : 92.41 (-0.87%)
3 Dividend Stock ETFs to Buy With $2,000 and Hold Forever

There is no shortage of excellent, low-cost exchange-traded funds (ETFs) that specialize in dividend stocks. There are some that focus on stocks that pay above-average dividends, stocks whose dividends...

AAPL : 193.16 (-1.94%)
AVGO : 166.21 (-2.80%)
VIG : 180.17 (-2.01%)
JPM : 228.99 (-1.28%)
VYMI : 72.76 (-0.32%)
VNQ : 85.03 (-2.08%)
AMT : 217.99 (-2.10%)
TM : 174.52 (-1.05%)
PLD : 98.63 (-3.40%)
VYM : 118.70 (-1.77%)
EQIX : 773.20 (-2.15%)
Boost Your Income! Why This Closed-End Fund Surpasses Vanguard's High Dividend Yield ETF

Vanguard High Dividend Yield ETF (NYSEMKT: VYM) is a fairly easy to understand exchange-traded fund (ETF) with an income focus. There's just one glaring problem with the ETF: Its yield isn't exactly huge...

$SPX : 5,158.20 (-2.36%)
GDV : 22.05 (-2.00%)
VYM : 118.70 (-1.77%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Charles River Laboratories International, Inc. is a full service, early-stage contract research organization. The company provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions globally accelerate their research...

See More

Key Turning Points

3rd Resistance Point 108.55
2nd Resistance Point 106.23
1st Resistance Point 104.45
Last Price 102.67
1st Support Level 100.35
2nd Support Level 98.02
3rd Support Level 96.24

See More

52-Week High 254.15
Fibonacci 61.8% 192.16
Fibonacci 50% 173.01
Fibonacci 38.2% 153.86
Last Price 102.67
52-Week Low 91.86

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Unlock High-Probability Trade Setups: Master Fractals & Time Frames Like a Pro